System Maintenance Alert

Our website will be undergoing planned maintenance on May 29, 2024, at 8:30 PM ET. During this time, the site will be temporarily unavailable. We apologize for any inconvenience this may cause and appreciate your understanding.

Biosimilars in Patients with Crohn’s Disease Failing an Initial Biologic

Array

Activity Info

Upon completion of the activity, participants should be able to explain the circumstances – and rationale – under which it is appropriate to initiate or switch a patient with inflammatory bowel disease to a biosimilar.
2. Explain the circumstances under which it is appropriate to initiate or switch a patient with inflammatory bowel disease to a biosimilar
Email

CME/CE credit is no longer available for this activity.

Search